Anthea Lee

Variant-agnostic modulation of gene expression to identify novel treatments for genetic neuromuscular disorders

Genetic neuromuscular disorders (NMDs) that predominantly affect muscle tissue are individually rare but cumulatively are responsible for significant clinical and economic burdens on patients and healthcare systems. Few effective, targeted therapies exist outside of the Duchenne muscular dystrophy (DMD) landscape, high...